Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? — CARS-2  

Arthroplasty Complications Clinical Trial

Official title: From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (CARS 2: Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability Measured With CT-based Motion Analysis (CTMA)?).

Status Recruiting

Clinical Trial Summary

This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).

Clinical Trial Description

Lateralization of reverse shoulder arthroplasties may reduce the risk for complications such as limited range of motion (ROM), and scapular notching, where the lower part of the scapular neck becomes eroded due to impingement against the humeral component. There's several ways to lateralize the glenoid component, a bone transplant placed underneath the glenoid component (Bony Increased Offset Reversed Shoulder Arthroplasty: BIO-RSA) has been used for some time. Recently glenoid components with metallic lateralization of the joint centre (Metal-Increased Offset Reversed Shoulder Arthroplasty: MIO-RSA) have been introduced, but there is not much comparative literature on metal vs. bony lateralization.

Patients with osteoarthritis and medialization of the glenoid articular surface, who willing to participate in a study will be randomized to receive either MIO-RSA or a BIO-RSA. CT-based motion analysis (CTMA) will be used to measure the 3-dimensional migration pattern of the glenoid components to assess the stability of the prostheses up to two years after implantation. ;

Related Conditions & MeSH terms

• Arthroplasty Complications
• Osteoarthritis
• Shoulder Osteoarthritis

• NCT number: NCT06025448
• Study type: Interventional
• Source: Lovisenberg Diakonale Hospital
• Contact: Christian Owesen, PhD
• Phone: +4790515843
• Email: cow@lds.no
• Status: Recruiting
• Phase: N/A
• Start date: October 30, 2023
• Completion date: March 1, 2033